The Molecular Basis of Malonyl-CoA Decarboxylase Deficiency  by FitzPatrick, David R. et al.
Am. J. Hum. Genet. 65:318–326, 1999
318
The Molecular Basis of Malonyl-CoA Decarboxylase Deficiency
David R. FitzPatrick,1 Alison Hill,1 John L. Tolmie,3 David R. Thorburn,2
and John Christodoulou4
1Human and Clinical Genetics Units, Molecular Medicine Centre, Western General Hospital, Edinburgh; 2The Murdoch Institute, Royal
Children’s Hospital, Melbourne, Australia; 3Duncan Guthrie Institute, Yorkhill, Glasgow; and 4Western Sydney Genetics Program, Royal
Alexandra Hospital for Children and Department of Paediatrics and Child Health, University of Sydney, Sydney, Australia
Summary
We characterized a 2.1-kb human cDNA with a 1362-
bp (454–amino acid) open reading frame showing
70.3% amino acid identity to goose malonyl-CoA de-
carboxylase (MCD). We have identified two different
homozygous mutations in human MCD (hMCD) by us-
ing RT-PCR analysis of fibroblast RNA from two pre-
viously reported consanguineous Scottish patients with
MCD deficiency. The first mutation is a 442CrG trans-
version resulting in a premature stop codon (S148X) in
the N-terminal half of the protein. The second is a 13-
bp insertion in the mature RNA, causing a frameshift
with predicted protein truncation. This insertion is the
result of an intronic mutation generating a novel splice
acceptor sequence (IVS4–14ArG). Both mutations were
found to segregate appropriately within the families and
were not found in 100 normal unrelated individuals.
These mutations would be predicted to cause MCD de-
ficiency, thus confirming this transcript as the hMCD
ortholog. The peptide sequence of hMCD revealed a C-
terminal peroxisomal targeting sequence (-SKL). This
targeting signal appears to be functional in vivo, since
the distribution of MCD enzymatic activity in rat liver
homogenates—as measured by means of subcellular
fractionation—strongly suggests that MCD is localized
to peroxisomes in addition to the mitochondrial local-
ization reported elsewhere. These data strongly support
this cDNA as encoding human MCD, an important reg-
ulator of fatty acid metabolism.
Introduction
Malonyl-CoA decarboxylase (MCD; EC 4.1.1.9) cata-
lyzes the conversion of malonyl-CoA to acetyl-CoA.
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MCD activity has been detected in both prokaryotes and
eukaryotes, but its only proven in vivo role is in the
production of erythromycin in bacteria (Hsieh and Ko-
lattukudy 1994). The cellular function of mammalian
MCD is not known. It may play a role in the regulation
of fatty acid synthesis and oxidation via the potent in-
hibitor of mammalian carnitine palmitoyltransferase I
(CPT1) by malonyl-CoA (Shi et al. 1998). The best ev-
idence for a critical role for MCD in any vertebrate
species comes from the study of a rare inborn error of
metabolism in humans. To date, seven cases of human
MCD deficiency (MIM 248360) have been reported (ta-
ble 1). This condition is present in early childhood and
is associated with malonic aciduria (7/7), methylmalonic
aciduria (7/7), developmental delay (7/7), seizure dis-
order (4/7), hypoglycemia (4/7), and cardiomyopathy (2/
7). In this study, we report the characterization of a
human MCD (hMDA) cDNA and the identification of
causative mutations in the hMCD gene in two patient
samples, and we present evidence that MCD is localized
to both mitochondria and peroxisomes in mammalian
cells.
Material and Methods
Identification of hMCD cDNA and Genomic Clones
The TBLASTN program was used to search dbEST
by means of the goose MCD peptide (gMCDp) sequence
(dbEST database; GenBank P12617). The sequences
identified were extended, and a consensus sequence was
generated by means of the ESTblast program (ESTblast).
Clones, obtained from the IMAGE consortium HGMP,
were then sequenced in both directions to confirm the
previous sequence and to fill in gaps. The sequence-
tagged site (STS) WI-11775, derived from one of the
cDNAs identified by TBLASTN searching, was used to
identify two human genomic clones from the de Jong
RPCI1 gridded P1 artificial chromosome (PAC) library
by means of PCR pools (supplied by the HGMP resource
center). Both cDNA and genomic sequencing were per-
formed by use of the ThermoSequenase cycle sequencing
kit with 33P-labeled dideoxynucleotides (Amersham).
Northern blot analysis was performed by use ofMultiple
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Table 1
Clinical Features of Patients with MCD Deficiency
Author(s) (year) Consanguinity Age
Delayed
Neurological
Development Seizures
Short
Stature
Sib
Death Acidosis Hypoglycemia Cardiomyopathy
Brown et al. (1984) Yes 5 years Yes No Yes Yes Yes No No
Haan et al. (1986) No 10 mo Yes No No No Yes Yes No
Matalon et al. (1993) No 7 mo Yes Yes No No No No Yes
MacPhee et al. (1993) Yes 3.9 years Yes Yes No No No No No
MacPhee et al. (1993) Yes 13 years Yes Yes No No No Yes No
Krawinkel et al. (1994) Yes 4 d Yes No No Yes Yes Yes No
Yano et al. (1997) No 4 years Yes Yes No No Yes Yes Yes
NOTE.—All patients were alive at the time of publication in July 1999.
Table 2
ESTs Identified with Significant Homology to gMCDp Sequence
EST Name Clone ID
Length
(bp) Source Library End Homologya Blast Score
AI123407 1690076 641 Mixed 5′ 53–253 275
AA291121 700476 329 Germinal Centre B cell 5′ 347–455 324
AA333449 135110 247 8-wk embryo 5′ 183–263 277
AA340389 142028 224 Fetal brain 5′ 429–502 300
R08989b 127540 371 Fetal liver and spleen 5′ 395–442 166
a Region of amino acid homology to the gMCD sequence (GenBank P12617).
b Sequence from the 3′ end of this clone was previously used to design the hMCD STS WI-
11775.
Choice Northern Blot (OriGene), according to manu-
facturer’s instructions.
Fibroblast Culture, RT-PCR Analysis, and
Characterization of Mutations
Fibroblast cells from two children with MCD defi-
ciency (designated “case 1” and “case 2,” as in the orig-
inal report; MacPhee et al. 1993) and four unrelated
control fibroblast lines were cultured in Eagle’s Basal
Medium with 10% fetal calf serum, 100 U/ml penicillin,
and 100 mg/ml streptomycin. The fibroblasts were har-
vested by means of a solution containing trypsin 0.025
g/100 ml, 0.5 mM EDTA (trypsin/EDTA). Total cellular
RNA was prepared by means of the RNA Isolation kit
(Stratagene). Five micrograms of total cellular RNA
from each fibroblast line were reverse transcribed by
means of the RT-PCR kit (Stratagene), according to the
manufacturer’s instructions. PCR amplification of the
coding region was done in seven different reactions by
using primer pairs MCD1-7 (table 3) under standard
reaction conditions (Saiki et al. 1988). PCR cycle con-
ditions were identical for all primer pairs by using a hot-
start (80C # 3 min, 94C # 2 min) followed by a
touch-down PCR with common denaturation and
extension segments (94C # 30 s, 72C # 1 min) and
the following annealing segments (59C# 30 s, 2 cycles;
58C# 30 s, 2 cycles; 57C# 30 s, 30 cycles), followed
by a final extension segment (72C# 5 min). SSCP was
done by means of standard techniques (Axton et al.
1997). Direct sequencing of RT-PCR products was
achieved by using a ThermoSequenase cycle sequencing
kit with 33P-labeled dideoxynucleotides (Amersham).
Mutagenically separated PCR (MS-PCR) assays (Rust et
al. 1993) for the 442CrG and IVS4 -14ArG mutations
used primer sets MCD8 and MCD9, respectively (table
3).
Rat Liver Subcellular Organelle Isolation
Adult male Sprague-Dawley albino rats (150–210 g)
were killed by carbon dioxide asphyxiation, after which
their cervices were dislocated and their livers excised.
The protocol used for isolation of subcellular organelles
is essentially as described elsewhere (Singh and Poulos
1988), except that the pooled 16,500 g supernatants and
the crude peroxisomal fractions were centrifuged at
100,000 g for 60 min.
Enzyme Assays
MCD (E.C. 4.1.1.9) was assayed radiochemically. The
reaction mixture (volume 400 ml) contained 50 mM KPi
(pH 7.4), 253 mM [1,3 14C]malonyl-CoA (New England
Nuclear Research Products, specific activity 0.75 mCi/
mmol), cell extract, and BSA to give a total protein con-
centration in the reaction mixture of 0.4 mg/ml. The
reaction mixture was incubated for 3 h at 37C and the
evolved 14CO2 was trapped and counted (Fox 1971). For
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Table 3
Intron-Exon Boundaries of hMCD
No. 5′ Junction Exon Size 3′ Junction
1 410a ATCCAGgtaagggg
2 cttttcagGAAATG 113 CAGTGAgtaagtat
3 gcccccagGGCTGA 156 ATCCAGgtacctgc
4 ttttccagGCAATC 150 TTGCAGgtaagcga
5 ctttacagAGAGAG ∼1230
a Number of bases from start of initiating codon to 3′ junction of
first exon.
the pH optima studies, a buffer solution consisting of
50 mM Mes, 25 mM Tris, 25 mM ethanolamine, and
100 mM sodium chloride with the pH for each buffer
adjusted to 4.5–10 with either hydrochloric acid or so-
dium hydroxide was used instead of the potassium phos-
phate buffer. Citrate synthase (CS;mitochondrialmarker
enzyme), catalase (peroxisomal marker enzyme), and
NADPH-cytochrome c reductase (NADPHCR; micro-
somal marker enzyme) were all assayed as described else-
where (Sottocasa et al. 1967; Shepard and Garland
1969; Aeib 1974). Lactate dehydrogenase (LDH; cyto-
plasmic marker enzyme) was assayed by means of a
modification of a previously published method (Berg-
meyer and Bernt 1974). The reaction mixture (total vol-
ume 1 ml) consisted of 50 mM potassium phosphate
buffer, pH 7.4, 1 mM pyruvate (freshly made each day),
0.25 mM NADH, and the cell fraction (5–70 mg pro-
tein). The rate of oxidation of NADH was followed
spectrophotometrically at 340 nm. All assays were per-
formed in duplicate, and the results shown are means.
Protein levels were measured spectrophotometrically
(Lowry et al. 1951) or fluorometrically (Udenfriend et
al. 1972), with BSA as the standard.
Results
hMCD cDNA
A TBLASTN search (Altschul et al. 1990) with the
gMCDp sequence identified five highly homologous hu-
man-expressed sequence tags (ESTs) (table 2), and sub-
sequent BLASTN and estBLAST searches identified an
additional nine cDNA clones. Six of these clones were
obtained and sequenced, and a 2117-base consensus se-
quence encoding a 1,362-base (454–amino acid) open
reading frame (ORF) was submitted to GenBank
(AF097832). Screening of 5# 105 primary clones from
a human fetal muscle cDNA library (HGMP) identified
three additional clones, all truncated at the 5′ end. 5′
rapid amplification of cDNA ends (RACE) analysis by
use of polyA–selected RNA from fibroblasts and total
RNA from human fetal muscle failed to identify new
sequence information.
The position of the proposed initiating methionine
codon in the hMCD cDNA is identical to that of a trans-
lation start site identified in the goose (Courchesne Smith
et al. 1992). The sequence surrounding this AUG codon
was analyzed bymeans of the human data available from
the TransTerm database. This analysuis demonstrated a
good consensus initiation sequence context on the basis
of 16,000 sequences in the public databases. The ob-
served likelihood of each base being observed at a set
position from the initiation codon was compared to the
sequence of MCD. The bases 5′ of the AUG (GGGCC)
were seen in 29%, 25%, 38%, 40%, and 48%, respec-
tively, of known initiation sequences. The equivalent fig-
ures for the bases 3′ of the AUG (GACGA) were 49%,
27%, 27%, 37%, and 26%. Although the ORF in the
human transcript continued 5′ of this AUG for 60 ba-
ses, no other in-frame AUG or stop codons could be
identified. However, no significant amino acid homology
with the “extra” 50 amino acids of the goose peptide
could be detected in any reading frame in the human
ORF 5′ to the ATG.
Genomic Clone Analysis
Two human genomic PAC clones were isolated by use
of an STS WI-11775, described elsewhere (Schuler et al.
1996), which was used to map one of the MCD EST
clones on radiation hybrid panels. Direct sequencing of
these PAC clones revealed five exons (table 3) with per-
fect conservation of the position of the intron-exon
boundaries between the human and goose genes (Cour-
chesne Smith et al. 1992). Unfortunately, sequencing of
the 5′ end of this gene has proven very difficult because
of the high CG content. We are currently making a small
insert library from these PAC clones to facilitate iden-
tification of other possible 5′ coding regions and pro-
moter sequences.
Tissue Distribution of hMCD
We were unable to identify a hybridization signal by
using a 1.8-kb hMCD cDNA probe on a commercial
northern blot made with 2 mg polyA–selected RNA
from several human tissues including heart, liver, and
brain (data not shown). This problemwas expected from
work done elsewhere (Jang et al. 1989) on the goose, in
which very large amounts of polyA RNA (1100 mg)
were required to detect any MCD hybridization signal
on a northern blot. PCR analysis of human cDNA ob-
tained from HGMP yielded a faint product in fetal mus-
cle cDNA but no visible product in either placental or
HepG2 cDNA. Interestingly, RT-PCR reactions using
normal human fibroblast RNA yielded product with
every primer pair tested.
Predicted hMCD Protein Product
The hMCD cDNA has an ORF of 454–amino acid
product that shows 70.3% amino acid identity to g-
Figure 1 Alignment of the predicted hMCDp (GenBank AF097832) and gMCDp (GenBank P12617) sequences by use of ClustalW
interactive analysis program (ClustalW). This shows 70.3% identity of 1454 amino acids. The two characterized initiating methionines of the
goose peptide are shown in boldface type (position 1 and 50). C-terminal peroxisomal-targeting sequences were identified in both human and
goose sequences (-SKL) and are underlined. An ORF predicting a 360–amino acid peptide (GenBank Z46242) from a C. elegans gene (labeled
“Nematode”) from chromosome III also showed a high degree of homology on searching and is likely to be orthologous. There was 35.8%
sequence identity among all three peptides.
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Figure 2 Case 1 mutation. A, Electrophoresis of RT-PCR prod-
ucts from the patients in case 2 (lane 1) and in case 1 (lane 2) and
from the controls (lanes 3–6), with use of primer pair MCD3 with
silver-stained SSCP (top) and primers MCD4F andMCD3R (predicted
normal product size of 105 bp) with ethidium bromide–stainedagarose
gel analysis (bottom). Both analyses show a larger fragment in case
1, with no evidence of a normal band. B, Sequence of genomic PCR
product from the patient in case 1 and a normal control showing ArG
at position 14 in intron 4 (IVS4 –14ArG). The larger fragment
shown in A was due to the creation of a novel 3′ splice site within the
intron, thus creating the 13-bp insertion in the cDNA (CCATGCTT-
TACAG), as detailed in the two bottom panels. C, 2% agarose gel
electrophoresis of MSPCR products by means of primer-set MCD8,
showing appropriate segregation of the mutation within the nuclear
family of the patient in case 1 (lane 4), homozygous mutant larger
band (113 bp) for patients with both parents heterozygous (lanes 2
and 3), and a normal control homozygous smaller band (93 bp, lane
5). The DNA size marker ladder (L) shows 100-bp (lower) and 200-
bp (upper) bands in lane 1.
Table 4
Primers Used for PCR Amplification
Namea Forward Reverse
Product
Size
MCD1 AGGCGAGGACCGGCTGCG GCCAGGTAACCCGTTCTAGGTTCAG 231
MCD2 AATGAATGGGGTGCTGAAAG ATGGAGGATGTTCCTTCACG 293
MCD3 GTGGCACTGACTGGTGACAT ACCCCAAGGTGAGGAAACTC 209
MCD4 ATTCCATCAGCTTGACCCAG GGAGCTTGAGGGTCTCGTTA 267
MCD5 TCGTCAAGGAGTTGCAGAGA CTCCATACAGGTACCAGGCG 294
MCD6 CCCATTAACGAGACCCTCAA CTCCTCCAGGAAGTAGCGGT 273
MCD7 CCAACTTCCACCTGCAGAAC GATCGTTTTCTTAGCCGGG 270
MCD8 (MT) GGTGCTCCTCTGTTGGTAACGTA AGACTTGAAAACACCCCAAGGTGAGGAAACTCT
CTCTGTAAAGCATCGC 113
MCD8 (WT) GGTGCTCCTCTGTTGGTAACGTA GTGAGGAAACTCTCTCTGTAAAGCATGCT 93
MCD9 (MT) TATCTTCTCCTTTTCAGGAAATGAATGGGG
TGCTGAAAGGAATGCTCGG ACTTACTCACTGATTTTCTGAAGCAC 138
MCD9 (WT) ATGAATGGGGTGCTGAAAGGAATGCGCTC ACTTACTCACTGATTTTCTGAAGCAC 118
MCD10 GACCGCTACACAGCAGCAT TTCCGAATCTGTAAAGAGTTCA 244
a MT  mutant allele; WT  normal (wild-type) allele.
MCDp on ungapped alignment ( fig. 1). A predicted gene
on C. elegans chromosome III (GenBank Z46242) en-
codes the only other highly homologous peptide (35.8%
amino acid identity) identified by public database
searches. A potential peroxisomal (-SKL) targeting se-
quence (Gould et al. 1990) was present at the C-terminus
of the human protein. No other specific protein domains
were recognized, and, in particular, no mitochondrial
targeting sequence (MTS) could be identified.
Mutations in hMCD
RT-PCR analysis was performed on fibroblast RNA
from two Scottish patients with MCD deficiency (cases
1 and 2), reported elsewhere (MacPhee et al. 1993), and
four control cell lines. The coding region was amplified
with primer pairs MCD1-7, listed in table 4. The RT-
PCR products were then analyzed by SSCP and direct
sequencing. Probable causative homozygous mutations
were identified in both patients. The patient in case 1
was found to have an SSCP band shift by means of
primer pairs MCD3 and MCD4 (fig. 2A). Direct se-
quencing of these PCR products revealed an apparently
homozygous 13-bp insertion, rather than the wild-type
sequence. This insertion was apparent on agarose gel
electrophoresis with no evidence of the wild-type se-
quence in either this analysis or the silver-stained SSCP
gel (fig. 2A). To clarify the genomic basis of this mu-
tation, the genomic PAC clone was directly sequenced
by use of the primer MCD4R. This revealed an intron-
exon junction in the position predicted from the known
goose sequence (table 3). It was noted that the sequence
5′ of the splice acceptor site in normal DNAwas identical
to the 13 bases inserted into the mRNA of the patient
in case 1. Primer pair MCD10 was designed to amplify
this region from genomic DNA. Direct sequencing of
this product by means of genomic DNA from the patient
in case 1 revealed an apparently homozygous ArG sub-
stitution at position 14 in intron 4 (fig. 2B). This mu-
tation (IVS4 –14ArG) showed appropriate segregation
within the family (fig. 2C) and was not detected in anon-
ymous testing of 100 normal unrelated individuals from
the cystic fibrosis screening program by means of anMS-
PCR assay.
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Figure 3 Case 2 mutation. Sequences of RT-PCR product from
patient in case 2 and a healthy control show an apparently homozygous
CrG transversion at nucleotide 442 in the cDNA, denoted by an
asterisk (*). This results in the change of a serine codon (TCA) to a
stop codon (TGA) at position 148 in the peptide (S148X).
Figure 4 Marker-enzyme studies of rat liver organelle fractions.
Enzyme activities were assayed in duplicate. The means of the specific
activities are plotted for each organellar fraction. Abbreviations:
homog.  homogenate; mito.  mitochondrial fraction; micro. 
microsomal fraction; perox.  peroxisomal fraction; and super. 
supernatant.
In the patient in case 2, direct sequencing of the PCR
yielded by primer pair MCD1 showed a CrG substi-
tution at nucleotide 442 in the apparently full-length
cDNA. This results in the formation of a premature stop
codon (S148X) in the N-terminal half of the wild-type
peptide (fig. 3). An MS-PCR assay was developed for
this mutation, which confirmed the parents as hetero-
zygous. This mutation was not detected in anonymous
testing of 100 normal unrelated individuals from the
cystic fibrosis screening program.
Subcellular Localization of MCD in Rat Liver
The results of enzyme assays of the organelle fractions
obtained from rat liver are shown in figure 4. There was
enrichment of catalase in the peroxisomal fraction and
CS in the mitochondrial fraction, whereas NADPHCR
was highest in the microsomal fraction. LDH activity
was highest in the final supernatant. In addition, it can
be seen that there was little contamination of mito-
chondria in the peroxisomal fraction (low CS activity)
and little contamination of peroxisomes in the mito-
chondrial fraction (low catalase activity). There was,
however, some microsomal contamination of peroxi-
somes (high levels of NADPHCR). It is of note that
comparable MCD activity was found in both the mi-
tochondrial and the peroxisomal fractions, clearly in-
dicating that peroxisomes have MCD activity of their
own far outweighing any potential contamination by
mitochondrial MCD. This set of experiments was re-
peated twice with the same overall marker enzyme pat-
tern being found, although the absolute specific activities
differed somewhat.
MCD activity in mitochondrial and peroxisomal frac-
tions was assayed in duplicate at 0.5 unit intervals from
pH 4.5–10.0. The mean values of the specific activities
are plotted in figure 5. It can be seen that the pH optima
for the two forms of the enzyme are quite similar. Max-
imal activity for both the mitochondrial and peroxi-
somal enzymes was found at pH 5.0, with a secondary
peak at pH 8.0–8.5 (peroxisomal form).
Discussion
The evidence that the cDNA presented in this report
encodes hMCD has three main components. First, there
is very highly significant sequence homology between
the putative hMCD and the goose MCD (gMCD) at the
level of both cDNA and predicted peptides. When com-
pared to the goose gene, there is also perfect conserva-
tion in the position of the human intron-exon junctions.
Second, we report that different homozygous mutations
have been identified in two patients previously found to
be deficient in MCD enzyme activity. Both these muta-
tions are predicted to result in premature truncation in
the N-terminal half of the protein, and it is highly likely
that these represent loss-of-function mutations. Third,
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Figure 5 pH studies of rat liver mitochondrial and peroxisomal
preparations. MCD activity was assayed in duplicate. The means of
the specific activities are plotted for each organellar fraction. Two
peaks—one at pH ∼4.5–5.0 and the second at pH ∼8.0–8.5—could
be identified for both preparations.
the discovery of a C-terminal peroxisomal targeting se-
quence in hMCD peptide (hMCDp) correctly predicted
the dual localization of MCD enzyme activity in mam-
malian cells. Peroxisomal localization of MCD has not
been reported elsewhere.
The subcellular localization of MCD has been most
extensively studied in the uropygeal (preening) gland of
the domestic goose. In this tissue, it is expressed at a
remarkably high level, accounting for ∼1% of cellular
protein (Kim and Kolattukudy 1978b). MCD activity is
probably required to promote methylmalonyl-CoA (via
methylmalonyl-acyl carrier protein) as a substrate for
fatty acid synthase, thus enabling the synthesis of mul-
tiple methyl-branched fatty acids (Kolattukudy et al.
1987). Characterization of the goose cDNA and ge-
nomic structure revealed an interesting mechanism for
the control of subcellular localization of MCD (Jang et
al. 1989; Courchesne Smith et al. 1992). This gene uses
two alternative transcription start sites that result in tis-
sue-specific control of subcellular localization of the pro-
tein product. The larger transcript is translated to a 55-
kDa protein with an N-terminal MTS; the smaller
transcript produces a protein that is 5 kDa smaller than
the mitochondrial form and was thought to result in a
cytosolic protein. The position of the initiating methi-
onine codon in this smaller transcript in the goose is
identical to the putative initiating codon in the human
cDNA (fig. 1). This would strongly argue that the human
cDNA encodes a functional MCD protein. It is inter-
esting to note that the studies on subcellular localization
of the goose protein did not use peroxisomal markers
(Scholte 1969; Kim and Kolattukudy 1978a). It may be
useful to reassess these studies in view of the fact that
the gMCDp also has a predicted C-terminal peroxisomal
targeting sequence (-SKL) (Gould et al. 1990).
In humans, the best information regarding the sub-
cellular localization of MCD comes from the study of
urinary metabolites in human patients deficient in this
enzyme activity. The presence of methylmalonic aciduria
in MCD deficiency is thought to be because of the in-
hibition of the mitochondrial enzyme methylmalonyl-
CoA mutase by malonyl-CoA. Intramitochondrial for-
mation of malonyl-CoA is thought to occur as a result
of low-level carboxylation of acetyl-CoA by propionyl-
CoA carboxylase. Malonyl-CoA cannot be transported
into or out of the mitochondrion; thus, MCD has a
scavenging function in this organelle. It was expected
that cloning of the 5′ end of the hMCD gene would
identify an MTS in hMCDp. This prediction was made
on the basis of the functional MTS identified in the
gMCDp sequence (Courchesne Smith et al. 1992) and
previous subcellular localization studies of mammals
(Scholte 1969; Kim and Kolattukudy 1978a). However,
in spite of extensive dbEST searching, cDNA-library
screening, 5′ RACE, and genomic sequencing, an MTS
could not be identified by use of theMitoProt II program
(Claros and Vincens 1996).
The failure to identify an MTS may simply reflect the
fact that we have not identified the full-length MCD
transcript. Since we have been unable to size either the
mRNA or native peptide, it is not possible to exclude
the presence of another 5′ exon that encodes the “miss-
ing” mitochondrial targeting information. Sequencing
the PAC clones containing the MCD gene and the pro-
duction of MCD antisera will help clarify the situation.
It is also possible that an MTS exists in our sequence
but cannot be identified by current computer prediction
programs. In any event, since the sequences flanking the
putative AUG have a good Kozak consensus sequence
and since an equivalent initiation codon is used in the
goose, it is reasonable to assume that it may also be used
to initiate translation in humans and produce a func-
tional protein.
The localization of MCD to both mitochondria and
peroxisomes may be important in the regulation of fatty
acid oxidation via the powerful inhibition of CPT1 by
malonyl-CoA (A’Bhaird and Ramsay 1992). Acetyl-CoA
carboxylase (ACC), a cytoskeleton-associated enzyme
(Geelen et al. 1997), is the only enzyme proven to syn-
thesize malonyl-CoA. The role of ACC in malonyl-CoA-
mediated regulation of fatty acid oxidation has beenwell
studied (Zhang and Kim 1996; Abdel-Aleem et al.
1998). In contrast, little is known of the role that MCD
plays in this system. It will be particularly important to
investigate the possible role of MCD in cardiomyocytes
(Hall et al. 1996; Dyck et al. 1998), given the finding
of cardiomyopathy in some patients with MCD defi-
ciency. The two reported patients with cardiac involve-
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ment had chronic malonic aciduria, in contrast to the
other patients, whose urine malonate tended to be ele-
vated only during episodes of acute illness. It may be
that cardiomyopathy occurs only after prolonged ex-
posure to high levels of malonate.
It is also interesting to speculate that the develop-
mental delay associated with MCD deficiency is due to
the inhibition of peroxisomal beta-oxidation. The en-
dogenous synthesis of certain polyunsaturated fatty ac-
ids (PUFA) known to be critical for normal brain de-
velopment requires peroxisomal beta-oxidation (Ander-
son et al. 1990; Moore et al. 1995). The pattern ofMCD
activity in the developing brain would support the idea
of an important role for this protein (Dickson et al.
1994). The inhibition of endogenous PUFA synthesis
may also mediate the reported effect of mild MCD de-
ficiency as a risk factor for hyperlipidemia (Halliday et
al. 1988; Nydahl et al. 1994). This effect will be of
particular interest, since it may lead to the development
of novel therapeutic approaches to MCD deficiency.
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